PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24526N0553Patient medication of pomalyst 2mg 3mng — Bristol-Myers Squibb Company

Bristol-Myers Squibb Company holds $17.3M across 91 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36E79726A0010. PoP ended May 4, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

245-Network Contract Office 5 (36C245)
Awarding office
Bristol-Myers Squibb Company
Recipient
May 4, 2026
PoP end
$139K
Obligated
$139K
Potential
325412
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Bristol-Myers Squibb Company — $90

Contract facts

Federal
Contract number36C24526N0553
Also listed as36C245-26-N-0553
Also listed as36E79726A0010-36C24526N0553
Agency245-Network Contract Office 5 (36C245)
Awarding office245-Network Contract Office 5 (36C245)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentBristol-Myers Squibb Company
CAGE4K2D9
UEIUFGKB2B71N12
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36E79726A0010
Place of performanceMEMPHIS TN
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startApr 27, 2026
PoP end (current)May 4, 2026
Obligated$139K
Current value$139K
Potential value$139K

PATIENT MEDICATION OF POMALYST 2MG, 3MNG, 4MG. TO BE SHIPPED TO THE BALTIMORE VA MEDICAL CENTER. is a federal award for 245-Network Contract Office 5 (36C245) held by Bristol-Myers Squibb Company. Estimated value $139K ($139K obligated). Current period of performance ends May 4, 2026. Place of performance: MEMPHIS TN.

PATIENT MEDICATION OF POMALYST 2MG, 3MNG, 4MG. TO BE SHIPPED TO THE BALTIMORE VA MEDICAL CENTER.

Recompete timing

Public
Past PoP end (109 days ago)

Current PoP ended May 4, 2026 (109 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Bristol-Myers Squibb Company$17.3M obligated across 91 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($17.3M) · all agencies
Department of Veterans Affairs (VA)$17.3M · 100%Department of Justice (DOJ)$23K · 0%
Open full company profile

Related awards

Same parent · incumbent
36C24926F0137
BREYANZI CAR T-TRANSPLANT
$364K
Aug 31, 2026
36C24526N0790
POMALYST 2 MG, 3 MG,4 MG
$199K
Aug 31, 2026
36C24926N0526
BREYANZI CAT-T TRANSPLANT
$364K
Sep 1, 2026
36C24926F0096
ABECMA FOR CAR-T
$379K
Sep 12, 2026
36C24926N0589
BREYANZI CAR T
$364K
Sep 17, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C24526N0553?

36C24526N0553 (Patient medication of pomalyst 2mg 3mng) is a 245-Network Contract Office 5 (36C245) award with a potential value of $139K, currently held by Bristol-Myers Squibb Company. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C245-26-N-0553?

36C245-26-N-0553 is the dashed form of PIID 36C24526N0553 (Patient medication of pomalyst 2mg 3mng), held by Bristol-Myers Squibb Company. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24526N0553?

245-Network Contract Office 5 (36C245) awarded 36C24526N0553 to Bristol-Myers Squibb Company (potential $139K).

Who is the incumbent on 36C24526N0553?

Bristol-Myers Squibb Company is the incumbent with $17.3M across 91 related awards in SCOUT’s public footprint. The current period of performance ends May 4, 2026.

When does Bristol-Myers Squibb Company’s 36C24526N0553 come up for recompete?

SCOUT tracks a period-of-performance end of May 4, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C24526N0553